000 | 02026 a2200589 4500 | ||
---|---|---|---|
005 | 20250515153934.0 | ||
264 | 0 | _c20090428 | |
008 | 200904s 0 0 eng d | ||
022 | _a1535-4970 | ||
024 | 7 |
_a10.1164/rccm.200809-1512OC _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWenzel, Sally E | |
245 | 0 | 0 |
_aA randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. _h[electronic resource] |
260 |
_bAmerican journal of respiratory and critical care medicine _cApr 2009 |
||
300 |
_a549-58 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForced Expiratory Volume |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfections _xetiology |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aBarnes, Peter J | |
700 | 1 | _aBleecker, Eugene R | |
700 | 1 | _aBousquet, Jean | |
700 | 1 | _aBusse, William | |
700 | 1 | _aDahlén, Sven-Erik | |
700 | 1 | _aHolgate, Stephen T | |
700 | 1 | _aMeyers, Deborah A | |
700 | 1 | _aRabe, Klaus F | |
700 | 1 | _aAntczak, Adam | |
700 | 1 | _aBaker, James | |
700 | 1 | _aHorvath, Ildiko | |
700 | 1 | _aMark, Zsuzsanna | |
700 | 1 | _aBernstein, David | |
700 | 1 | _aKerwin, Edward | |
700 | 1 | _aSchlenker-Herceg, Rozsa | |
700 | 1 | _aLo, Kim Hung | |
700 | 1 | _aWatt, Rosemary | |
700 | 1 | _aBarnathan, Elliot S | |
700 | 1 | _aChanez, Pascal | |
773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 179 _gno. 7 _gp. 549-58 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1164/rccm.200809-1512OC _zAvailable from publisher's website |
999 |
_c18584645 _d18584645 |